HomeInvestingETFsPanna Sharma Discusses LTRN Collaboration With John Hopkins On Brain Tumor Treatment
Panna Sharma Discusses LTRN Collaboration With John Hopkins On Brain Tumor Treatment

Panna Sharma, President, CEO and Director of Lantern Pharma, describes Lantern as a clinical-stage biopharmaceutical company. He says they are currently developing seven drug candidates in solid tumors. They developed a proprietary DARD A.I. platform to discover biomarker signatures for precision oncology drug discovery and development.

The Watch List

14 Apr 2021

ON AIR
11:00 pm
Trading 360
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
ON AIR
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US